The use of specific antisense probes against Cx32, Cx26, and Cx43 on in vitro ischemia paradigms have shown that the silencing of Cx26 and Cx32 simultaneously, or of Cx43, significantly reduces cell death [229]. The gene discussed is GJB2; the disease is ischemia.